146 related articles for article (PubMed ID: 8983841)
1. [Inotropic agents: why yes and why not].
Ferrari M; Magnolfi G; Piovan D; Bertagna E
Cardiologia; 1996 Sep; 41(9):831-41. PubMed ID: 8983841
[No Abstract] [Full Text] [Related]
2. The future of inotropic drugs in clinical practice.
Smith TW
Eur Heart J; 1982 Dec; 3 Suppl D():149-56. PubMed ID: 6130948
[No Abstract] [Full Text] [Related]
3. Clinical application of inotropic drugs.
Counihan TB
Eur Heart J; 1982 Dec; 3 Suppl D():143-7. PubMed ID: 7160398
[No Abstract] [Full Text] [Related]
4. [Recent therapy of heart failure].
Sasayama S
Nihon Naika Gakkai Zasshi; 1995 Mar; 84(3):434-8. PubMed ID: 7751784
[No Abstract] [Full Text] [Related]
5. [Highlights from a symposium on the treatment of heart failure].
Zhonghua Xin Xue Guan Bing Za Zhi; 1984 Dec; 12(4):257-61. PubMed ID: 6544207
[No Abstract] [Full Text] [Related]
6. [Exercise test in the evaluation of the efficacy of drug therapy].
Febo O; Cobelli F
Ital Heart J Suppl; 2000 Mar; 1(3):393-9. PubMed ID: 10815269
[No Abstract] [Full Text] [Related]
7. Pharmacologic management of heart failure: positive inotropic agents.
Cross JA
Crit Care Nurs Clin North Am; 1993 Dec; 5(4):589-97. PubMed ID: 8297549
[TBL] [Abstract][Full Text] [Related]
8. [Guide to intensive care of refractory heart decompensation].
Frigerio M; Gronda E; Mangiavacchi M
G Ital Cardiol; 1994 Oct; 24(10):1275-84. PubMed ID: 7835556
[No Abstract] [Full Text] [Related]
9. [Modern evaluations of the activity of inotropic agents].
Dalla Volta S
G Ital Cardiol; 1986 Mar; 16(3):250-1. PubMed ID: 2942435
[No Abstract] [Full Text] [Related]
10. [Current role of non-digitalis inotropic agents in acute and chronic treatment of heart failure].
Dei Cas L; Nodari S; Raddino R; Metra M; Pelà G; Nardi M
Cardiologia; 1994 Mar; 39(3):209-15. PubMed ID: 8039201
[No Abstract] [Full Text] [Related]
11. [Digitalic therapy. Historical outline].
de Micheli-Serra A
Gac Med Mex; 2000; 136(5):511-8. PubMed ID: 11080935
[TBL] [Abstract][Full Text] [Related]
12. Inotropic agents in the treatment of heart failure: despair or hope?
Sasayama S
Cardiovasc Drugs Ther; 1997 Jan; 10(6):703-9. PubMed ID: 9110113
[TBL] [Abstract][Full Text] [Related]
13. Medical treatment of congestive heart failure: where are we now?
Parmley WW
Circulation; 1987 May; 75(5 Pt 2):IV4-10. PubMed ID: 3552301
[No Abstract] [Full Text] [Related]
14. Digitalis for patients with heart failure.
Vine DL
Kans Med; 1989 May; 90(5):151-2. PubMed ID: 2747109
[No Abstract] [Full Text] [Related]
15. Beta-blocking agents and positive inotropic agents in the therapy of chronic heart failure.
Erdmann E; Schwinger R; Böhm M
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S138-44. PubMed ID: 11527118
[TBL] [Abstract][Full Text] [Related]
16. [Crataegus in cardiology].
Blesken R
Fortschr Med; 1992 May; 110(15):290-2. PubMed ID: 1634169
[TBL] [Abstract][Full Text] [Related]
17. Advances in the evaluation and management of chronic cardiac failure.
Weber KT; Likoff MJ; Janicki JS; Andrews V
Chest; 1984 Feb; 85(2):253-9. PubMed ID: 6363000
[No Abstract] [Full Text] [Related]
18. [Why are results of studies with digitalis so poor? "It depends on potassium!"].
Hien M
MMW Fortschr Med; 2003 Oct; 145(43):21. PubMed ID: 14652934
[No Abstract] [Full Text] [Related]
19. [Digitalis in acute heart failure].
Marcus FI
Ter Arkh; 1982; 54(11):101-4. PubMed ID: 7157157
[No Abstract] [Full Text] [Related]
20. Clinical and circulatory aspects of digitalis in heart failure.
Storstein L
Eur Heart J; 1982 Dec; 3 Suppl D():59-64. PubMed ID: 6761128
[No Abstract] [Full Text] [Related]
[Next] [New Search]
